Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Oil Prices Surge as U.S.-Iran Conflict Escalates and Strait of Hormuz Risks Grow 
EU Weighs New Trade Restrictions on Israeli West Bank Settlements 
US-Iran Strikes Escalate as Strait of Hormuz Crisis Pushes Oil Prices Higher 
Australian Business Conditions Hold Steady as Easing Cost Pressures Face New Oil Price Risks 
Asian Stocks Slide as Oil Surge, U.S.-Iran Tensions and Fed Rate Bets Weigh on Markets 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
European Stocks Slip as Middle East Tensions and Hormuz Threat Rattle Markets 
Australia Consumer Sentiment Rises in July as Fuel Price Relief Lifts Confidence 
Gordie Howe Bridge to Open July 27 After U.S.-Canada Reach Toll Revenue Agreement 
Dollar Holds Steady Ahead of U.S. CPI as Oil Surge, Middle East Tensions Keep Markets on Edge 
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Japanese Yen Holds Steady as Intervention Hopes Grow Ahead of U.S. CPI Data 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Tofurky, a processor of plant-analog proteins, will collaborate with Triton Algae Innovations to develop products incorporating protein from “essential red” algae.
Jaime Athos, CEO of Tofurky, said that the opportunity for the companies to combine their knowledge and understanding of the plant-based market with the nutrition and natural supply-chain technology created by Triton’s algae is unique and timely.
The process involves the selection and cultivation of algae strains that are rich in protein, omega-3 fatty acids, and other beneficial nutrients.
The products would be rolled out in the first quarter of next year, although the company's announcement did not furnish any descriptions or other specifics.
Athos noted that while they can’t share just yet what the products are, it would resonate with their core audience and be attractive to the rapidly growing flexitarian segment who are increasingly drawn to plant-based foods.
